'Electronic skin' could revolutionize breast cancer detection
9/15/2014

Scientists are developing an 'electronic skin' that could detect and image small lumps that are currently undetectable by clinicians.

Using MRI and PET to monitor the response to treatment in bone metastases
9/15/2014

A review and position statement of the EORTC Imaging GroupImaging technologies are very useful in evaluating a patient's response to cancer treatment, and this can be done quite effectively for...

Nintedanib in combination with paclitaxel achieves total remission of tumors in 50 percent of HER-2-negative breast cancer patients
9/14/2014

The experimental drug nintedanib, combined with standard chemotherapy with paclitaxel, causes a total remission of tumours in 50% of patients suffering from early HER-2- negative breast cancer, the...

Improved survival of ovarian cancer patients receiving treatment guided by comprehensive tumour profiling
9/12/2014

Data from an ovarian cancer registry presented at the European Society for Gynaecological Oncology (ESGO) annual meeting reinforce comprehensive tumour profiling as a 'game changer' for oncologists.

Genomic analysis reveals that a high-risk leukemia subtype becomes more common with age
9/12/2014

More than one-quarter of young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and may benefit from drugs widely used to treat...

Improved survival of ovarian cancer patients receiving treatment guided by comprehensive tumour profiling
9/12/2014

Data from an ovarian cancer registry presented at the European Society for Gynaecological Oncology (ESGO) annual meeting reinforce comprehensive tumour profiling as a 'game changer' for oncologists.

Genomic analysis reveals that a high-risk leukemia subtype becomes more common with age
9/12/2014

More than one-quarter of young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and may benefit from drugs widely used to treat...

Ethnic disparities in cancer and genetic mutations linked
9/12/2014

One of the goals of genome sequencing is to identify genetic mutations associated with increased susceptibility to disease.

Ovarian cancer metastasis promoted by mesothelial cells
9/12/2014

Less than half of the women diagnosed with ovarian cancer will survive beyond 5 years.

Why damaged DNA contributes to cancer and other age-related illnesses
9/12/2014

As we and other vertebrates age, our DNA accumulates mutations and becomes rearranged, which may result in a variety of age-related illnesses, including cancers.